Optimizing API Bioavailability And Performance Using Particle Size Reduction Technologies

Summary: Particle Size Reduction is a critical manufacturing process for developing various types of dosage forms for small molecules. It’s beneficial in improving API content uniformity for commercial tablet manufacturing, suspension stability and/or feel of oral, topical, or ocular formulations, and is still a conventional technology for enhancing the oral and pulmonary bioavailability of small molecules. 

Click here to download